Measurement of blood-brain barrier permeability in a tumor model using magnetic resonance imaging with gadolinium-DTPA

Magn Reson Med. 1992 Sep;27(1):68-75. doi: 10.1002/mrm.1910270108.

Abstract

Sequential MR imaging with gadolinium-diethylenetriaminepentaacetic acid (Gd-DTPA) and sequential measurements of plasma Gd-DTPA concentration by inductively coupled plasma atomic emission spectroscopy (ICP-AES) were used to estimate the blood-to-tissue transport coefficient (Ki) in the 36B-10 rat glioma model. For these measurements, tissue Gd-DTPA concentration was estimated from tumor enhancement by correlation with calibration measurements obtained by ICP-AES analysis of tumor tissue. The 14 animals for which Ki was calculated can be grouped into those imaged at 11 days following tumor implantation, at 13-18 days, and at 20 days. The mean (+SEM) Ki values for these groups were 1.1 + 0.24, 9.2 + 0.8, and 13.4 + 1.7 ml/kg-min, respectively. These results correspond well with published data obtained by quantitative autoradiography. It is concluded that frequent sequential imaging and a graphical approach to Ki calculation are promising methods for determining the blood-to-tissue transport coefficient noninvasively by contrast-enhanced MRI.

MeSH terms

  • Animals
  • Astrocytoma / chemically induced
  • Astrocytoma / physiopathology*
  • Blood-Brain Barrier / physiology*
  • Brain Neoplasms / chemically induced
  • Brain Neoplasms / physiopathology*
  • Contrast Media*
  • Female
  • Gadolinium DTPA
  • Gadolinium*
  • Magnetic Resonance Imaging
  • Male
  • Neoplasm Transplantation
  • Organometallic Compounds*
  • Pentetic Acid*
  • Permeability
  • Rats
  • Rats, Inbred F344

Substances

  • Contrast Media
  • Organometallic Compounds
  • Pentetic Acid
  • Gadolinium
  • Gadolinium DTPA